Efficacy and Tolerability of Fimasartan, a New Angiotensin Receptor Blocker, Compared With Losartan (50/100 mg): A 12-Week, Phase III, Multicenter, Prospective, Randomized, Double-Blind, Parallel-Group, Dose Escalation Clinical Trial With an Optional 12-Week Extension Phase in Adult Korean Patients With Mild-to-Moderate Hypertension

✍ Scribed by Sang Eun Lee; Yong-Jin Kim; Hae-Young Lee; Han-Mo Yang; Chang-Gyu Park; Jae-Joong Kim; Soon-Kil Kim; Moo-Yong Rhee; Byung-Hee Oh

• Book ID: 113544593
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 806 KB
• Volume: 34
• Category: Article
• ISSN: 0149-2918
• DOI: 10.1016/j.clinthera.2012.01.024